Korean J Gastroenterol.  2021 Apr;77(4):149-150. 10.4166/kjg.2021.060.

The Effect of Proton Pump Inhibitor and Prokinetics Combination Therapy for Functional Dyspepsia

Affiliations
  • 1Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea


Reference

1. Lee H, Jung HK, Huh KC. Functional Dyspepsia Study Group in the Korean Society of Neurogastroenterology and Motility. 2014; Current status of functional dyspepsia in Korea. Korean J Intern Med. 29:156–165. DOI: 10.3904/kjim.2014.29.2.156. PMID: 24648796. PMCID: PMC3956983.
Article
2. Stanghellini V, Chan FK, Hasler WL, et al. 2016; Gastroduodenal disorders. Gastroenterology. 150:1380–1392. DOI: 10.1053/j.gastro.2016.02.011. PMID: 27147122.
Article
3. Oh JH, Kwon JG. 2019; Functional dyspepsia. Korean J Gastroenterol. 73:77–83. DOI: 10.4166/kjg.2019.73.2.77. PMID: 30845383.
Article
4. Min BH, Huh KC, Jung HK, et al. 2014; Prevalence of uninvestigated dyspepsia and gastroesophageal reflux disease in Korea: a population-based study using the Rome III criteria. Dig Dis Sci. 59:2721–2729. DOI: 10.1007/s10620-014-3243-y. PMID: 24925147.
Article
5. Park JM, Choi MG, Cho YK, et al. 2011; Functional gastrointestinal disorders diagnosed by Rome III questionnaire in Korea. J Neurogastroenterol Motil. 17:279–286. DOI: 10.5056/jnm.2011.17.3.279. PMID: 21860820. PMCID: PMC3155064.
Article
6. Park JK, Huh KC, Shin CM, et al. 2014; Current issues in functional dyspepsia. Korean J Gastroenterol. 64:133–141. DOI: 10.4166/kjg.2014.64.3.133. PMID: 25252861.
Article
7. Oh JH, Kwon JG, Jung HK, et al. 2020; Clinical practice guidelines for functional dyspepsia in Korea. J Neurogastroenterol Motil. 26:29–50. DOI: 10.5056/jnm19209. PMID: 31917913. PMCID: PMC6955183.
Article
8. Yang YJ, Bang CS, Baik GH, et al. 2017; Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis. BMC Gastroenterol. 17:83. DOI: 10.1186/s12876-017-0639-0. PMID: 28651565. PMCID: PMC5485548.
Article
9. Lee JW, Youn YH, Choi SC, Lee KJ, Kim N. 2021; Multicenter, randomized, placebo-controlled trial to evaluate the efficacy and safety of a controlled-release, once-daily UIC201609/UIC201610 combination therapy for functional dyspepsia: preliminary study. Korean J Gastroenterol. 77:171–178. DOI: 10.4166/kjg.2020.171. PMID: 33854007.
Article
10. Yoon H, Lee DH, Lee YH, et al. 2018; Efficacy and safety of UI05MSP015CT in functional dyspepsia: a randomized, controlled trial. Gut Liver. 12:516–522. DOI: 10.5009/gnl17416. PMID: 29938452. PMCID: PMC6143453.
Article
11. Azuma T. 2004; Helicobacter pylori CagA protein variation associated with gastric cancer in Asia. J Gastroenterol. 39:97–103. DOI: 10.1007/s00535-003-1279-4. PMID: 15069615.
Article
12. Yamaoka Y, Kato M, Asaka M. 2008; Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med. 47:1077–1083. DOI: 10.2169/internalmedicine.47.0975. PMID: 18552463. PMCID: PMC3732488.
Article
13. Pike BL, Porter CK, Sorrell TJ, Riddle MS. 2013; Acute gastroenteritis and the risk of functional dyspepsia: a systematic review and meta-analysis. Am J Gastroenterol. 108:1558–1564. DOI: 10.1038/ajg.2013.147. PMID: 23711623.
Article
14. Gwee KA. 2010; Post-infectious irritable bowel syndrome, an inflammation-immunological model with relevance for other IBS and functional dyspepsia. J Neurogastroenterol Motil. 16:30–34. DOI: 10.5056/jnm.2010.16.1.30. PMID: 20535323. PMCID: PMC2879823.
Article
15. Sugano K, Tack J, Kuipers EJ, et al. 2015; Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 64:1353–1367. DOI: 10.1136/gutjnl-2015-309252. PMID: 26187502. PMCID: PMC4552923.
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr